Get started
Author

Vincent Grobost

Observed names: Grobost, Vincent, V Grobost, V. Grobost, Vincent GROBOST, Vincent Grosbost
Observed institutions: Lyon 1 Université, Université Clermont Auvergne, Centre Hospitalier Universitaire de Besançon, Centre Hospitalier de Perpignan, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Louis Pradel, Infections Virales et Pathologie Comparée
ORCID: 0009-0003-5352-7949
Observed ORCID: 0009-0003-5352-7949
OpenAlex ID: A5067369506
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
2017 · Caroline Charlier, Élodie Perrodeau, et al. · The Lancet Infectious Diseases · 611
PDF
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
2022 · Ingrid M Bistervels, Andrea Buchmüller, et al. · The Lancet · 129
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
2022 · Arsene Mekinian, Lin Pierre Zhao, et al. · Leukemia · 108
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
2024 · Jerome Hadjadj, Yann Nguyen, et al. · Annals of the Rheumatic Diseases · 94
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients
2022 · Mohamed-Yacine Khitri, Alexis F Guedon, et al. · RMD Open · 91
PDF
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
2014 · Vincent Grobost, Chahera Khouatra, et al. · Orphanet Journal of Rare Diseases · 80
PDF
Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome
2020 · Charlotte Buvry, Lucie Cassagnes, et al. · Respiratory Medicine · 76
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX
2025 · Vincent Jachiet, Olivier Kosmider, et al. · Blood · 49
PDF
Givosiran in acute intermittent porphyria: A personalized medicine approach
2022 · Antoine Poli, Caroline Schmitt, et al. · Molecular Genetics and Metabolism · 49
PDF
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial
2023 · Sophie Dupuis‐Girod, Sophie Rivière, et al. · Journal of Internal Medicine · 47
PDF
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
2017 · Arsene Mekinian, Guillaume Dervin, et al. · Autoimmunity Reviews · 40
PDF
Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies
2021 · Julien Stievenart, Guillaume Le Guenno, et al. · European Respiratory Journal · 35
PDF
Pregnancy and primary Sjögren’s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies
2016 · C Ballester, V Grobost, et al. · Scandinavian Journal of Rheumatology · 33
Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
2017 · A S Resseguier, B Pereira, et al. · Lupus · 28
Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors
2024 · T. Al Tabosh, H. Liu, et al. · Angiogenesis · 24
PDF
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
2020 · Sophie Dupuis-Girod, Anne-Emmanuelle Fargeton, et al. · Journal of Clinical Medicine · 24
PDF
Axial calcium pyrophosphate dihydrate deposition disease revealed by recurrent sterile spondylodiscitis and epidural abscess
2013 · Vincent Grobost, Marielle Vayssade, et al. · Joint Bone Spine · 22
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
2022 · Thi Thao Truc Le, Guillaume Martinent, et al. · Orphanet Journal of Rare Diseases · 20
PDF
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
2024 · Pierre-André Jarrot, Adrien Mirouse, et al. · Human Vaccines & Immunotherapeutics · 19
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
2024 · Bénédicte Billi, Paul Cholley, et al. · Frontiers in Immunology · 18
PDF
Neurological manifestations in patients with VEXAS syndrome
2025 · Charlotte Bert-Marcaz, Étienne Fortanier, et al. · Journal of Neurology · 17
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series
2020 · Hervé Lobbes, Charles Dervout, et al. · Seminars in Arthritis and Rheumatism · 17
PDF
Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years
2019 · Laure Delaval, Aurélie Daumas, et al. · Autoimmunity Reviews · 17
PDF
Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study
2019 · on behalf of the French Study Group for Large Vessel Vasculitis (GEFA), S. Deshayes, et al. · Clinical Rheumatology · 14
Infundibuloneurohypophysitis Associated With Sjögren Syndrome Successfully Treated With Mycophenolate Mofetil: A Case Report
2016 · Camille Louvet, Salwan Maqdasy, et al. · Medicine · 12
Works count: 93
Citation count: 1,799
H-index: 19
I10-index: 28
Year
Topic
Type